Lonza at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Lonza brings 3 presentations to ESGCT 2026 in Hamburg. Its contributions cover non-viral cell engineering and vector supply, including large-volume electroporation of CD34, NK and T cells and a high-titre AAV production system for HEK293 lines. It also examines reproducibility in mesenchymal stem cell culture and extracellular vesicle formation.
| Organization | ESGCT 2026 Attendance |
|---|---|
Lonza Basel, Switzerland | ◆Platinum Sponsor |
Offers cell and gene therapy development and manufacturing services, testing, automation platforms and research tools from discovery to commercial supply. | Poster Wed Oct 28 1:30pm–3:30pm Clinical Translation of Nonviral Gene Editing: Efficient Electroporation of CD34+, NK, and T Cells in large volume Chair Thu Oct 29 1:30pm–2:30pm LUNCHTIME SYMPOSIUM: Lonza Manufacturing, CMC and access Poster Thu Oct 29 2:00pm–4:00pm A robust system for high-titer, platform-agnostic AAV production in HEK293 cell lines Poster Thu Oct 29 2:00pm–4:00pm Examination of reproducibility in 2D MSC culture and 3D extracellular vesicle formation |
Instantly find 20 buyers from Lonza
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction